| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, Chairman
3 companies
Edward A Kangas last filed a Form 4 in June 2025, as Director at THC. The filings on record cover 3 companies. Edward A Kangas's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Edward A Kangas a middling insider score of 50/100, based on 8 past trades. Over a 12-month horizon, 42.9% of those trades were profitable, with an average 12-month return of -17.2%.
At the last filing, the largest reported position was 47,138 shares of THC. The THC filings lean toward selling, a net 45,000 shares.
Edward A Kangas has 46 Form 4 filings on record from January 2015 to June 2025, across 4 companies: Director at Hovnanian Enterprises (HOV), 2015–2025; Director at Tenet Healthcare (THC), 2015–2019; Director at RTX (RTX), 2017, and 1 more.
The 75 reported transactions were 20 open-market sales, 18 stock awards, 18 option exercises and 17 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 14 sales worth about $9.5M.
The largest open-market sale was 14,341 shares of INTU at an average $104.62 on May 26, 2015, about $1.5M.
None of the 7 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from June 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | HOV Hovnanian Enterprises Inc | Director | Sell | 5,500 | $107.12 | $589,165.50 | -50.7% | +25.9% | - | |
| Mar 3, 2025 | HOV Hovnanian Enterprises Inc | Director | Sell | 2,000 | $101.51 | $203,020.00 | -15.0% | -9.7% | +23.2% | |
| Oct 14, 2024 | HOV Hovnanian Enterprises Inc | Director | Sell | 1,500 | $188.86 | $283,292.49 | -10.1% | -39.1% | -35.2% | |
| Aug 23, 2024 | HOV Hovnanian Enterprises Inc | Director | Sell | 4,000 | $232.21 | $928,834.19 | -21.3% | -23.2% | -36.0% | |
| May 31, 2024 | HOV Hovnanian Enterprises Inc | Director | Sell | 2,000 | $144.72 | $289,436.80 | -8.4% | +51.6% | -37.2% | |
| Dec 15, 2023 | HOV Hovnanian Enterprises Inc | Director | Sell | 5,000 | $154.51 | $772,550.00 | -17.4% | -7.9% | +5.2% | |
| Oct 9, 2023 | HOV Hovnanian Enterprises Inc | Director | Sell | 5,500 | $86.21 | $474,155.00 | -16.1% | +85.4% | +125.0% | |
| Mar 6, 2023 | HOV Hovnanian Enterprises Inc | Director | Sell | 10,000 | $66.62 | $666,170.00 | -21.6% | +34.8% | +124.3% | |
| Aug 28, 2019 | THC Tenet Healthcare Corp | Director | Sell | 45,000 | $20.28 | $912,600.00 | -48.8% | - | - | |
| Jan 4, 2016 | INTU Intuit Inc. | Director | Sale+OE | 10,000 | $93.53 | $935,276.00 | - | - | - |